You have to think that there are a s't load of companies and individuals watching and waiting. No one can know for sure who may be eyeing up ACTC. When the dam breaks, everyone will be trying to get in like they've done with so many other stocks over the years. Most don't want to put money in and let it sit without a payback, and even a loss in initial investment. WE ARE THE CHAMPIONS MY FRIEND, and WE'LL KEEP ON FIGHTING TIL THE END. Even with all the patients in trials at this point, it's actually a small amount and a very early stage of development. While we are all staring at the RPE cell research, some of the big money might actually be in the blood platelet development, at least initially and that is quite a ways off. People think that more is better when it comes to the increase in RPE cells, but that may not be true and they may be finding that out. Maybe the RPE cells need nucleus from your own eyes implanted in them before they get implanted in your eyeballs, or maybe I'm still suffering from a "wannabe-scientist" syndrome that keeps me endlessly analyzing everything..........Keep, let's just hope that this was all just a lot of fluff talk in the prelude to this company and stock really taking off.....I just hope I live long enough to see it !!!! YIKES !!!!
The latest from Maurie Hill 4/3/13 does not sound like she has improved at all and I think she received 100,000 injection. Now they are going to treat patients wit better sight. that seems to take forever. I am getting concerned
Vin, Maurie Hill has her 1 year checkup in July, so we should know then if she has any improvement in her treated eye. The good think is that she is so upbeat and positive about life, and she has stated in her blog that she hasen't noticed any deteriorationin her treated eye either, so it's just wait and see in July.
Keep, "investors" such as PE firms typically don't take major positions in companies through open market transactions - the reasons should be obvious. On cutting a deal with a firm, GR has talked about this numerous times. At this point in the development of the company, he feels that they would need to give away to much of the company to any large investor. Think about it, with all the unknowns if you were putting a large sum of money into this company you would want a huge stake of the future profits and you'd want to exercise substantial control.
I think we need to be closer to a commercially viable treatment before we see a deal like that.
Theres, but there seems to be no interest in ACT, and you'd think with them on the verge of a medical breakthough there would be much more talk about it, but there's barely a peep, especially not anything coming from the CEO. Now I find that a little concerning, and you don't, hopefully it's because you know something that others don't.